To raise antibodies against goat MSTN, the C - terminal region of goat MSTN (amino acids 266 — 375) was expressed in bacteria, purified with a nickel column and then
used as antigen to immunize rabbits.
Not exact matches
Currently, rising blood levels of prostate - specific
antigen (PSA), a protein made by the prostate gland, are
used as indicators of tumor recurrence.
The tools included TCRdist, which researchers
used to calculate the similarity and differences of key features of T cell receptors, such
as amino acid sequences in important regions for
antigen recognition.
The company wanted to
use it
as a diagnostic marker for disease: If synthetic versions of antibodies could be tagged with aequorin in the lab, then whenever they matched up with an
antigen (or surface protein) of a specific pathogen in blood or tissue, the sample would glow.
A recent study by investigators from LIJ Medical Center demonstrated that
using magnetic resonance imaging (MRI) in men with an elevated prostate specific
antigen (PSA) resulted in a prostate cancer detection rate that was twice
as high
as data reported in the March 1999 Prostate journal that analyzed men undergoing the standard 12 - core biopsy with an elevated PSA.
They gauged aggressiveness
using the results of the patients» prostate cancer - specific
antigen, or PSA, tests,
as well
as the clinical stage of their cancer and Gleason grade.
Ken Shea and colleagues at the University of California, Irvine,
used melittin, the toxin in bee venom,
as the
antigen (the substance triggering an immune reaction).
The other four candidates are tests that detect
antigens to Ebola in blood and other fluids — in many cases,
using the same strip format and analytical technique, called enzyme - linked immunosorbent assay (ELISA),
as over-the-counter pregnancy - test kits.
Over the past two years, investigators from the Perelman School of Medicine at the University of Pennsylvania have reported results from a human trial in GBM
using chimeric
antigen receptor (CAR) T cell therapy, through which patients» own T cells were engineered to track down and kill cancer cells that express a tumor - specific protein known
as EGFRvIII.
While the 3D injectable scaffold is being tested in mice
as a potential cancer vaccine, any combination of different
antigens and drugs could be loaded into the scaffold, meaning it could also be
used to treat infectious diseases that may be resistant to conventional treatments.
«The retraction states that Mignot and his colleagues were unable to replicate the results of the ELISpot assay, a widely
used method for measuring how immune system cells such
as T cells respond to fragments of foreign proteins, called
antigens,» Underwood writes.
It's hoped this latest insight will lead to the widespread
use of
antigen - specific immunotherapy
as a treatment for many autoimmune disorders, including multiple sclerosis (MS), type 1 diabetes, Graves» disease and systemic lupus erythematosus (SLE).
The transchromosomal cows
used by USAMRIID collaborator SAB Biotherapeutics, Inc. offer the opportunity to produce large quantities of antibodies that are fully «human,» meaning they will not be seen
as foreign
antigen by the human immune system.
Her dissertation looked at whether variants in the PSA gene — that is, the gene that codes for the PSA (prostate specific
antigen) protein doctors
use as a screen for the existence or recurrence of prostate cancer — had any influence on developing the cancer.
The laboratory has also all of the technologies required to produce recombinant bacteria expressing vaccine
antigens to be
used as non-pathogenic vaccine vectors.
Now
as an Assistant Professor in Medicine at Harvard Medical School, Daniel
uses membrane structure and function
as a means to define B cell
antigen recognition and inform vaccine design.
Moreover, UNISI produces recombinant bacteria expressing vaccine
antigens to be
used as non-pathogenic vaccine vectors.
The rational
use of adjuvants will be studied in detail,
as very often researchers
use a «shotgun» approach with adjuvants, testing entire panels with their
antigens in the search for improved immune responses.
Requires heat - induced
antigen retrieval where aldehydes are
used as fixatives.
We show that synNotch receptors can be
used to sculpt custom response programs in primary T cells: they can drive a la carte cytokine secretion profiles, biased T cell differentiation, and local delivery of non-native therapeutic payloads, such
as antibodies, in response to
antigen.
Currently, pDNA can be
used directly
as a therapeutic agent (e.g., in gene therapy or generation of vaccine
antigens) and indirectly for a range of applications.
[13] Highlighting this risk in the PD /
AS context, a preclinical study using a nitrated AS species similar to one found in patient LB as an active vaccine antigen developed worrisome autoimmunit
AS context, a preclinical study
using a nitrated
AS species similar to one found in patient LB as an active vaccine antigen developed worrisome autoimmunit
AS species similar to one found in patient LB
as an active vaccine antigen developed worrisome autoimmunit
as an active vaccine
antigen developed worrisome autoimmunity.
For the detection of specific
antigens, the following primary antibodies were
used: mouse monoclonal anti-Tuj1 (Covance, Princeton, NJ, USA)
as a neuronal marker, rabbit anti-L1 (kindly provided from Dr. Asou)[52] and rat monoclonal anti-L1 (Millipore, Billerica, MA, USA)
as granule cell markers, rabbit anti-calbindin D28K (Millipore)
as a Purkinje cell marker, and rabbit anti-glial fibrillary acidic protein (GFAP, DAKO, Denmark)
as an astrocyte marker.
His ongoing research projects include programs to develop adjuvants for
use with H5N1 pandemic influenza
antigens as well
as West Nile Virus vaccines.
Virus particles recovered from the interface between the two sucrose layers were
used as coating
antigen.
Areas of focus include: understanding how tumour - reactive T cells and B cells promote patient survival in cancer; defining the effects of standard treatments on tumor immunity; and
using genomic approaches to identify novel tumour mutations that can serve
as target
antigens for immunotherapy.
As noted above, existing cancer vaccines that
use dendritic cells require extracting cells from a patient's blood, treating them with an engineered protein or nucleic acid that combines tumor
antigens with immune - stimulating molecules, and returning the activated dendritic cells to the patient.
She
uses antigen therapy to desensitize patients to environmental allergens such
as molds, animals, pollens, and inhalants
as well
as chemicals and foods.
The assays,
antigens and controls
used are developed and validated
as a component of our research.
The most commonly
used vaccine against panleukopenia, herpesvirus and calicivirus is a multivalent vaccine: it contains viral
antigens for several diseases together in the same dose, and is commonly abbreviated
as the «FVRCP» vaccine.
The
use of whole tumor RNA
as the antigenic payload allows for an HLA - independent, whole
antigen approach that aims to promote a polyclonal anti-tumor T cell response.